Novo Nordisk A/S (NVO)

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Q: Do you still prefer LLY over NVO given the latest developments at NVO (pill)?

Read Answer Asked by Danny-boy on January 06, 2026

Q: What's the best way to play the GLP-1/Semaglutide bandwagon now that the WHO is encouraging its use as a way to better health through weight loss?

Read Answer Asked by John on December 03, 2025

Q: Has NVO fallen to a level you see as attractive?

Read Answer Asked by Kim on November 24, 2025